It’s ok to be skeptical! Come meet the staff, and let us meet you! First, our trained staff will show you our wall of client success stories, then, we’ll do a body composition analysis. It’s very detailed and will show valuable information like your body fat percentage, muscle mass, visceral fat and your metabolic age. If time permits, you may also do a mini-trial session. It’s just a few minutes under the LED technology, but you can experience what it’s like, and see that’s it’s pain-free and very relaxing! You will then meet with the Lipolysis Consultant who will answer all your questions. Many clients can start their first session the same day! What are you waiting for? Client results vary.
*In the U.S., the CoolSculpting®procedure is FDA-cleared for the treatment of visible fat bulges in the submental area, thigh, abdomen and flank, along with bra fat, back fat, underneath the buttocks (also known as banana roll), and upper arm. It is also FDA-cleared to affect the appearance of lax tissue with submental area treatments. In China, the cryolipolysis system is used for fat layer reduction of the abdomen and flanks. In Taiwan, the CoolSculpting procedure is cleared for the breakdown of fat in the flank (love handle), abdomen, and thigh. Outside the U.S., China and Taiwan, the CoolSculpting procedure for non-invasive fat reduction is available worldwide. CoolSculpting® and its design are trademarks of ZELTIQ Aesthetics, Inc., an Allergan affiliate. CoolSculpting is the treatment doctors use most for non-invasive fat removal.
"Be aware that we live in a very competitive environment whereby youth is king and people are looking for less-invasive procedures, and these procedures are now for the first time being directly marketed by the manufacturer in consumer magazines," points out session moderator Franklin L. DiSpaltro, MD, a plastic surgeon in West Orange, N.J., and a past president of ASAPS.
1 July 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.